The CoSolve programme from AstraZeneca seeks collaborators with innovative solutions to real research challenges worldwide. These challenges lie within Astrazeneca’s R&D research focus areas: cardiovascular science, renal and metabolism, respiratory immunology, oncology, neuroscience and microbial science. and require solutions that are immediately translatable.
Applications are open to academia, start-ups, and early-stage biotechs with expertise in these specialised areas. Proposals should be on innovative solutions that can be translated into practice within a 12–18-month timeframe. This opportunity provides access to AstraZeneca’s knowledge, resources and team.
Applications close on March 6, 2026.